The goal of this observational case-control study is to evaluate the relationship between temporal bone computed tomography (CT) findings, bone mineral density (BMD), and audiological parameters in adults diagnosed with otosclerosis. The main questions it aims to answer are: Is there a correlation between temporal bone CT density values and the severity of hearing loss in otosclerosis? Do bone mineral density and serum vitamin D levels differ between otosclerosis patients and individuals without otosclerosis? Researchers will compare patients diagnosed with otosclerosis to a control group without otosclerosis to determine if CT-based density variations are associated with disease severity and systemic bone metabolism markers. Participants who have already had a temporal bone CT scan as part of their routine clinical evaluation will undergo: Bone mineral density (BMD) assessment via dual-energy X-ray absorptiometry (DEXA) Serum vitamin D level measurement Audiological testing, including pure tone audiometry and speech discrimination tests This study aims to improve the diagnostic and prognostic understanding of otosclerosis by integrating imaging, metabolic, and audiological data.
Study Type
OBSERVATIONAL
Enrollment
86
Hacettepe University Hospitals
Ankara, Turkey (Türkiye)
RECRUITINGTemporal Bone CT Density Measurements
Measurement of bone density at key anatomical sites including the stapes footplate, oval window, and otic capsule, using Hounsfield Units (HU) from high-resolution temporal bone CT scans.
Time frame: Baseline (Preoperative assessment)
Pure Tone Audiometry (PTA) Thresholds
Hearing thresholds will be assessed using pure tone audiometry (PTA) across standard frequencies (500 Hz, 1000 Hz, 2000 Hz, 4000 Hz). The average PTA threshold (in dB HL) will be reported to evaluate the severity of hearing impairment.
Time frame: Baseline (Preoperative assessment)
Air-Bone Gap (ABG) Measurement
Air-bone gap (ABG) will be assessed at key frequencies (500 Hz, 1000 Hz, 2000 Hz, 4000 Hz) using pure tone audiometry. The mean ABG value (in dB HL) will be reported to evaluate the degree of conductive hearing loss.
Time frame: Baseline (Preoperative assessment)
Bone Mineral Density (BMD) Scores
Measurement of bone mineral density in lumbar spine and femoral neck using Dual-Energy X-ray Absorptiometry (DEXA) to explore systemic bone metabolism in otosclerosis patients.
Time frame: Baseline (Preoperative assessment)
Serum Vitamin D Levels
Measurement of 25-hydroxyvitamin D levels in blood samples to assess vitamin D status and its potential correlation with otosclerosis progression.
Time frame: Baseline (Preoperative assessment)
Correlation Between CT Density and Audiological Parameters
Analysis of the relationship between preoperative CT bone density values and audiometric findings to determine if CT markers predict hearing loss severity.
Time frame: Baseline (Preoperative assessment)
Association Between Otosclerosis Severity and BMD/Vitamin D Levels
Statistical analysis to determine whether systemic bone metabolism markers (BMD, serum vitamin D) correlate with otosclerosis severity, as assessed by CT and audiological tests.
Time frame: Baseline (Preoperative assessment)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.